Learning hematology in 2025 with Nico Gagelmann: Part 3

Learning hematology in 2025 with Nico Gagelmann: Part 3

Nico Gagelman is a physician and scientist who co-founded and co-chairs the European Society for Blood and Marrow Transplantation (EBMT) Trainee Committee, and he also serves as the chair of the EBMT subcommittee focused on CAR-T cell therapies for plasma cell disorders.

His work is particularly impactful in the realm of CAR-T treatments for multiple myeloma, where he has contributed to advancing research and clinical approaches.

Nico Gagelmann

Recently Nico Gagelmann began a new series on X titled ‘Let’s Learn Hematology in 2025.’ Here’s the third part of his educational journey:

Evaluation of hemolysis

hematology

Hemophilia characteristics

How to manage febrile neutropenia

Hyperleukocytosis

Targeted therapies in CLL

Bone marrow in aplastic anemia

Hemoglobin degradation

Synthesis and function of von Willebrand factor

Thrombocytopenia in liver cirrhosis

Malignancy-associated haemophagocytic lymphohistiocytosis

Nico Gagelmann: Let’s learn hematology in 2025: Part 1

Learning hematology in 2025 with Nico Gagelmann: Part 2